Christopher Dodd

Has grant

Research Associate

Newcastle University
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

The Labour Party's Policy for the Modernisation of Britain's Hospitals 1951-1970

Open Date:

Close Date:

Articles (6)

Aim To design and develop a novel co‐produced intervention tool aimed at facilitating discussions that lung cancer nurses have with lung cancer patients about clinical trial opportunities; and promote trial recruitment. Design A multi‐phase qualitative focus group (phase 1) and co‐production (phase 2) study. Methods The rigorous design and content of the intervention tool was informed by qualitative data from seven focus groups with lung cancer healthcare professionals ( n = 38) and patients and their carers ( n = 22) to establish barriers and facilitators to clinical trial participation. Data collection took place across England and Scotland between October and December 2023. Findings from a previously published systematic review were also incorporated to inform intervention tool design. The tool was developed through an extended co‐production workshop comprising lung cancer nurses ( n = 7), lung cancer patients ( n = 2) and health researchers ( n = 4). The COM‐B model of behavioural change underpinned both phases of the project to guide tool development. Results Phase 1 focus groups identified the need for a tool to provide basic trial information to patients, and to support lung cancer nurses in discussing trials with patients, thus improving nurses' knowledge, confidence, and awareness of trials. The phase 2 coproduction workshop identified that the tool should consist of two elements: a patient‐facing information pamphlet and a large poster for nurses to assist them in discussing trial opportunities. Conclusion The study results demonstrate how nurses can be supported to discuss clinical trial opportunities with patients, with the potential to increase long‐term recruitment to clinical trials. Implications for the Profession and/or Patient Care Lung cancer nurses often lack confidence to support patients to make informed choices about trial enrolment. By addressing this issue, participation in lung cancer clinical trials can be significantly improved to benefit patient outcomes and trial participation rates. Impact The tool has the potential to be used across a range of different cancer settings and sites to increase recruitment to clinical trials. Reporting Method The COREQ checklist was utilised to ensure that robust processes were followed and reported on. Patient and Public Involvement Patients and members of the public were involved in all study processes and contributed to the study design, interpretation of the data, and intervention design. Their contributions included reviewing focus group topic guides, reviewing data analysis, the co‐production of the intervention tool, and co‐authoring this paper, ensuring the research addressed the needs and priorities of lung cancer patients when making an informed choice about clinical trial participation.

Year:

2026

Year:

2026

Year:

2026

As the proportion of people diagnosed with lung cancer who have never smoked rises, it is important to understand how their experiences differ from those of smokers. A better understanding of their experiences, views, and informational and supportive care needs is essential to ensuring an optimised patient-centred care pathway leading to improvements in patient satisfaction, quality of life, and treatment outcomes. This integrative review of the international literature identified 5866 articles by searching four academic databases, the grey literature, and hand-searching the reference lists of relevant systematic reviews. After screening, ten studies were selected for inclusion in the review. Thematic analysis identified five themes that spoke to the experiences of never smokers with lung cancer: stigma, awareness, diagnosis, the emotional response, and support. Stigma pervades, with potentially significant psychological and social consequences, negatively affecting patients emotionally and potentially delaying their diagnosis. Increasing awareness amongst healthcare professionals and the general public has the potential to reduce stigma and encourage earlier diagnosis. Support specifically tailored for never smokers with lung cancer can improve individuals’ experiences of care. The experiences of never smokers with lung cancer are unique, and more research is required to better tailor support and guidance for this cohort.

Year:

2025

Year:

2024

Year:

2024

Collaborators (6)

Clair Merriman

Divsional Lead for NMAHP Research and Innovation

Oxford Brookes University

UNITED KINGDOM
View details

Catherine Henshall

Professor

Oxford Brookes University

UNITED KINGDOM
View details

Susan Schutz

Senior Lecturer

Oxford Brookes University

UNITED KINGDOM
View details

Benjamin Lond

Research Associate

De Montfort University

UNITED KINGDOM
View details

Iain R. Williamson

-

UNITED KINGDOM
View details

Emma Davies

Reader in Psychology

Oxford Brookes University

UNITED KINGDOM
View details